Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Exclusion criteria typically include recent bariatric surgery, use of other weight loss medications within a washout period, significant cardiovascular events in the recent past, and certain endocrine disorders that could confound the results
It is currently in Phase 3 trials, and FDA approval is not expected until late 2026
04 What to pair and what to separate The three products are built to hand off to each other: cleanse, soften, then leave-on
Color Clear, colorless solution Contraindications Not for use in children, pregnant or breastfeeding women CAS Number 143045-27-6 Sterility Sterile, pyrogen-free Concentration 1 mg/ml Prescription Required Yes Molecular Weight 9,200 Daltons Administration Route Subcutaneous or intramuscular injection Side Effects Possible hypoglycemia, joint pain, swelling, injection site reactions Shelf Life After Opening 28 days (if kept refrigerated) IGF-1 LR3 Injection Trade Information Minimum Order Quantity 50 Vials Payment Terms Cash in Advance (CID) Supply Ability 1000 Vials Per Month Delivery Time 2-5 Days Main Export Market(s) Asia About IGF-1 LR3 Injection Experience the majestic benefits of IGF-1 LR3 Injection by Pharmacopeia-highly recommended for adults seeking muscle recovery, growth promotion, or anti-aging support
There is no single winner in the Mounjaro vs Ozempic question
However, the starting dose is intentionally low, designed for tolerability rather than therapeutic effect
